| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$493 |
Update - Notification of buy-back - WQG
|
13 Jun 2025 10:32AM |
$1.795 |
$1.785 |
fallen by
0.56%
|
|
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$192 |
Proposed issue of securities - CBE
|
13 Jun 2025 10:31AM |
$0.046 |
$0.200 |
risen by
334.78%
|
|
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$192 |
Underwritten Loyalty Options Prospectus
|
13 Jun 2025 10:31AM |
$0.046 |
$0.200 |
risen by
334.78%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobre Limited is offering up to 91,060,961 new options to eligible shareholders via an underwritten pro-rata non-renounceable loyalty option issue.
- Eligible shareholders will receive one new option for every ten shares held as at the record date, with options issued for free.
- Each option is exercisable at $0.08 and expires on 30 June 2026.
- If all options are exercised, the company could raise up to approximately $7.28 million before costs.
- Funds raised will be used for exploration and development activities, working capital, and costs of the offer.
- The offer is fully underwritten by Canaccord Genuity (Australia) Limited.
- The prospectus includes details on eligibility, option terms, risks, company background, and legal disclosures.
- Directors and management hold significant interests in the company and may participate in the offer.
- The document discusses potential risks such as exploration risks, commodity price volatility, and dilution for existing shareholders.
- The offer is only available to eligible shareholders with registered addresses in Australia or New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$192 |
Placement and Fully Underwritten Loyalty Options Offer
|
13 Jun 2025 10:30AM |
$0.046 |
$0.200 |
risen by
334.78%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobre Ltd is undertaking a Placement to raise approximately A$5.7 million from institutional and sophisticated investors.
- A fully underwritten Loyalty Options Offer is being made to all eligible existing Cobre shareholders on the record date.
- Funds raised will be used primarily for an extensive drilling program at the Ngami Copper Project (NCP) in Botswana.
- The drilling campaign aims to define a maiden Mineral Resource at NCP within the Kalahari Copper Belt.
- Placement shares will be issued at $0.06 per share, representing a discount to recent trading prices.
- Shareholders participating in the Loyalty Options Offer will receive one free option for every three shares held.
- The Loyalty Options will have an exercise price of $0.10 per share and an expiry date of 30 June 2026.
- The offer is fully underwritten by Canaccord Genuity (Australia) Limited.
- Key dates, offer terms, and capital structure implications are outlined in the document.
- Directors and management involved in the Placement, showing a strong alignment with shareholders.
- The capital raising supports Cobre's growth strategy and commitment to delivering value through exploration success.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
EQR Progresses Regional Tungsten Hub Strategy
|
13 Jun 2025 10:28AM |
$0.120 |
$0.062 |
fallen by
48.33%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited updates on the IVX platform's research and collaboration progress.
- EQR progresses its regional tungsten hub strategy with new exploration milestones.
- Strategic partnerships are being formed to support project development.
- Recent exploration results support the viability of the tungsten hub.
- The announcement reiterates commitment to advancing innovation and market presence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$10 |
Change in Director Interest Notice (IR & DF)
|
13 Jun 2025 10:27AM |
$0.003 |
$0.004 |
risen by
60%
|
|
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$493 |
Renewal of Existing On-Market Share Buy-Back
|
13 Jun 2025 10:25AM |
$1.780 |
$1.785 |
risen by
0.28%
|
|
WQG - Price-sensitive ASX Announcement
Full Release
Key Points
- WCM Global Growth Limited (WQG) announced the renewal of its on-market share buy-back.
- The buy-back permits purchasing up to 10% of issued shares over a 12-month period from 15 July 2024.
- Purpose of the buy-back is for capital management and to return capital to shareholders.
- Buy-back supports shareholders, especially when the share price is at a discount to NTA.
- The company is well-capitalised and the buy-back will not affect investment objectives or obligations.
- Actual shares to be bought back depend on market conditions and board discretion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$3,646 |
Notification regarding unquoted securities - AMP
|
13 Jun 2025 10:23AM |
$1.228 |
$1.440 |
risen by
17.31%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$533 |
Change of Director's Interest Notice (David Surveyor)
|
13 Jun 2025 10:20AM |
$4.515 |
$3.750 |
fallen by
16.94%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$194 |
May 2025 Investment Update
|
13 Jun 2025 10:15AM |
$0.975 |
$0.985 |
risen by
1.03%
|
|
| Whitefield Industrials Limited (WHF) ORDINARY FULLY PAID |
Financials |
$591 |
Net Tangible Asset Backing - May 25
|
13 Jun 2025 10:13AM |
$5.690 |
$4.890 |
fallen by
14.06%
|
|
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,772 |
Change of Director's Interest Notice - David Cataford
|
13 Jun 2025 10:12AM |
$4.175 |
$4.950 |
risen by
18.56%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$415 |
Proposed issue of securities - INR
|
13 Jun 2025 10:11AM |
$0.115 |
$0.135 |
risen by
17.39%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$75 |
Net Tangible Asset Backing May 2025
|
13 Jun 2025 10:11AM |
$1.510 |
$1.400 |
fallen by
7.28%
|
|
| NH3 Clean Energy Limited (NH3) ORDINARY FULLY PAID |
Materials |
$63 |
Investor Webinar Presentation
|
13 Jun 2025 10:10AM |
$0.035 |
$0.089 |
risen by
154.29%
|
|
NH3 - Price-sensitive ASX Announcement
Full Release
Key Points
- NH3 Clean Energy Limited is focused on ammonia (NH3) as a carbon-free energy carrier and fuel.
- The company has developed proprietary technology for efficient ammonia cracking to release hydrogen.
- NH3 is highlighted as a safe, cost-effective, and scalable solution for hydrogen transport and storage.
- NH3 Clean Energy targets the decarbonization of hard-to-abate sectors such as shipping, industry, and power generation.
- The presentation outlines significant market opportunities due to global commitments to reduce carbon emissions.
- The company's business model includes product sales, licensing, and partnership-driven deployment.
- NH3 Clean Energy is progressing through technology validation, pilot projects, and early commercial deployments.
- Strategic partnerships with industry leaders and research institutions are central to the company's approach.
- Market drivers include tightening emission regulations, green hydrogen policies, and the need for alternative fuels.
- The document presents a commercialization roadmap, with upcoming milestones and projected financial growth.
- Investor engagement is sought to accelerate technology deployment and capture emerging market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Change of Director's Interest Notice - A Dyer
|
13 Jun 2025 10:05AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,772 |
Notification regarding unquoted securities - CIA
|
13 Jun 2025 10:03AM |
$4.225 |
$4.950 |
risen by
17.16%
|
|
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$72 |
Monthly Funds Under Management- 31 May 2025
|
13 Jun 2025 10:02AM |
$0.810 |
$0.730 |
fallen by
9.88%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Monthly update of Pengana Capital Group's Funds Under Management (FUM) as of 31 May 2025.
- Detailed FUM breakdown by individual funds and investment strategies.
- Month-on-month comparison and calculation of FUM movement.
- Commentary provided to explain significant changes in FUM across products.
- Contact details for further information or shareholder inquiries.
- Information is directed towards shareholders and the investment community.
- Data reflects performance, inflows, and outflows for each fund during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$415 |
Investor Presentation - Equity Raising
|
13 Jun 2025 10:00AM |
$0.115 |
$0.135 |
risen by
17.39%
|
|
| Adriatic Metals Plc (ADT) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
13 Jun 2025 9:59AM |
$5.000 |
$6.220 |
risen by
24.40%
|
|
ADT - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested for Adriatic Metals Plc (ASX: ADT) effective 3 June 2024.
- The trading halt is due to a pending announcement regarding a proposed capital raising.
- Trading halt is to ensure the market remains fully informed.
- Securities will remain in pre-open until normal trading resumes or announcement is made.
- The halt will end at the earlier of the announcement release or 5 June 2024.
- The process complies with the requirements of ASX Listing Rule 17.1.
- Company provided confirmation that the trading halt is not due to any other reason.
- The halt was requested to prevent trading on an uninformed basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$415 |
US$16M Placement to Move Project through Partnering Process
|
13 Jun 2025 9:59AM |
$0.115 |
$0.135 |
risen by
17.39%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- ioneer Ltd raised approximately US$16 million through an institutional placement.
- The funds will support ongoing development of the Rhyolite Ridge Lithium-Boron Project in Nevada, USA.
- The placement was well supported by both existing and new institutional investors.
- The capital will fund permitting, engineering, and strategic partnering activities.
- The company is progressing a formal partnering process for the project.
- Rhyolite Ridge is positioned as a significant source of lithium for the US supply chain.
- ioneer emphasizes sustainability, regulatory compliance, and stakeholder engagement as core project values.
- The placement strengthens ioneer's financial position as it advances towards production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,094 |
SABRE topline results
|
13 Jun 2025 9:58AM |
$2.340 |
$2.940 |
risen by
25.64%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals announced topline results from the SABRE trial for 64Cu-SAR-bisPSMA (CU6).
- The SABRE trial focused on men with biochemical recurrence (BCR) of prostate cancer.
- Primary endpoint was met: safety and detection of PSMA-positive lesions.
- Key secondary endpoint of sensitivity was also achieved.
- CU6 demonstrated favorable safety profile with no serious adverse events related to the product.
- High sensitivity and clear imaging of prostate cancer recurrence were demonstrated.
- Results support further clinical development and regulatory submissions.
- CU6 offers potential benefits in logistics and broader clinical adoption due to copper-64's longer half-life.
- Clarity’s proprietary Targeted Copper Theranostics platform underpins the development of CU6.
- The SABRE study results represent a significant milestone for Clarity Pharmaceuticals’ diagnostic product pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adriatic Metals Plc (ADT) ORDINARY FULLY PAID |
Materials |
- |
Pause in Trading
|
13 Jun 2025 9:55AM |
$5.000 |
$6.220 |
risen by
24.40%
|
|
ADT - Price-sensitive ASX Announcement
Full Release
Key Points
- Adriatic Metals Plc requested a temporary pause in trading on the ASX.
- The pause is pending an upcoming material announcement.
- Trading will resume at the earlier of the announcement or at the start of trading on 24 June 2024.
- The trading halt is to ensure the market is properly informed.
- The company confirmed there are no reasons why the pause should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
Loyalty Option Entitlement Offer
|
13 Jun 2025 9:54AM |
$0.120 |
$0.062 |
fallen by
48.33%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited (IVX) announces a Loyalty Option Entitlement Offer for shareholders.
- Eligible shareholders can apply for one new loyalty option for every two IVX shares held as of the record date.
- The exercise price for each loyalty option is $0.016, expiring 30 June 2025.
- The offer is non-renounceable and aims to reward existing shareholders and potentially raise capital.
- Funds raised will support ongoing research and development, especially the Photosoft technology.
- The offer includes a detailed timetable, eligibility rules, and risk factors for investors.
- Shareholders are provided with instructions for applying and information on the consequences of not participating.
- The document outlines risks associated with IVX, including business, financial, and market risks.
- Directors and substantial shareholders’ intentions regarding participation in the offer are disclosed.
- Use of proceeds includes funding clinical trials, regulatory activities, and working capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$96 |
Notification regarding unquoted securities - HPG
|
13 Jun 2025 9:54AM |
$0.815 |
$0.700 |
fallen by
14.11%
|
|
Call 1300 880 160
Start a chat
Schedule a call
